Evidence-Based Medicine Guidelines
Intravenous immunoglobulin for the treatment of Kawasaki disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for the Treatment of Kawasaki Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456775/all/_________Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease______.
Intravenous immunoglobulin for the treatment of Kawasaki disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456775/all/_________Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease______. Accessed October 2, 2023.
Intravenous immunoglobulin for the treatment of Kawasaki disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456775/all/_________Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease______
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 October 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456775/all/_________Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for the treatment of Kawasaki disease
ID - 456775
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456775/all/_________Intravenous_immunoglobulin_for_the_treatment_of_Kawasaki_disease______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
